Cargando…

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia

CONTEXT: Standard glucocorticoid therapy in congenital adrenal hyperplasia (CAH) regularly fails to control androgen excess, causing glucocorticoid overexposure and poor health outcomes. OBJECTIVE: We investigated whether modified-release hydrocortisone (MR-HC), which mimics physiologic cortisol sec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merke, Deborah P, Mallappa, Ashwini, Arlt, Wiebke, Brac de la Perriere, Aude, Lindén Hirschberg, Angelica, Juul, Anders, Newell-Price, John, Perry, Colin G, Prete, Alessandro, Rees, D Aled, Reisch, Nicole, Stikkelbroeck, Nike, Touraine, Philippe, Maltby, Kerry, Treasure, F Peter, Porter, John, Ross, Richard J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063257/ https://www.ncbi.nlm.nih.gov/pubmed/33527139 http://dx.doi.org/10.1210/clinem/dgab051

Ejemplares similares

OR25-02 A Phase 3 Study of a Modified-Release Hydrocortisone in the Treatment of Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2020)

RF09 | PSAT70 Comparison of Prednisolone Versus Modified-release Hydrocortisone (Efmody) in the Treatment of Congenital Adrenal Hyperplasia (CAH)
por: Merke, Deborah P, et al.
Publicado: (2022)

SAT304 Improved Biochemical Control With Dose Reduction In Chronic Glucocorticoid Therapy: A Phase III Extension Study Of Chronocort (Efmody) In The Treatment Of Congenital Adrenal Hyperplasia (CAH)
por: Ross, Richard John M, et al.
Publicado: (2023)

Alterations in Hydrocortisone Pharmacokinetics in a Patient With Congenital Adrenal Hyperplasia Following Bariatric Surgery
por: Mallappa, Ashwini, et al.
Publicado: (2017)

Management challenges and therapeutic advances in congenital adrenal hyperplasia
por: Mallappa, Ashwini, et al.
Publicado: (2022)

Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Verhees, Myrthe J. M., et al.
Publicado: (2021)

Body Image and Quality of Life in Women with Congenital Adrenal Hyperplasia
por: Tschaidse, Lea, et al.
Publicado: (2022)

Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia
por: Jones, Christopher M., et al.
Publicado: (2016)

Congenital Adrenal Hyperplasia Presenting as an Adrenal Mass With Increased (18)F-FDG Positron Emission Tomography Uptake
por: Mallappa, Ashwini, et al.
Publicado: (2017)

SAT-069 A Case of Congenital Hypoaldosteronism Due to Aldosterone Synthase Deficiency Misdiagnosed as Classic Congenital Adrenal Hyperplasia
por: Mallappa, Ashwini, et al.
Publicado: (2019)

Positive fertility outcomes in a female with classic congenital adrenal hyperplasia following bilateral adrenalectomy
por: Dagalakis, Urania, et al.
Publicado: (2016)

Individualizing Management of Infertility in Classic Congenital Adrenal Hyperplasia and Testicular Adrenal Rest Tumors
por: Jha, Smita, et al.
Publicado: (2019)

RF33 | PSAT68 Gonadotropin-Releasing Hormone Agonist Therapy Does Not Affect Bone Mineral Density in Congenital Adrenal Hyperplasia: a Clinical Study
por: Flokas, Myrto, et al.
Publicado: (2022)

MON-171 Characterization of the Adrenal Gland and Adrenal Rest Tissues in Congenital Adrenal Hyperplasia
por: Kolli, Vipula, et al.
Publicado: (2020)

Androgens correlate with increased erythropoiesis in women with congenital adrenal hyperplasia
por: Karunasena, Nayananjani, et al.
Publicado: (2016)

MON-158 Rates of Illnesses in Patients with Congenital Adrenal Hyperplasia
por: Mallappa, Ashwini, et al.
Publicado: (2020)

A TNXB splice donor site variant as a cause of hypermobility type Ehlers–Danlos syndrome in patients with congenital adrenal hyperplasia
por: Lao, Qizong, et al.
Publicado: (2020)

Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery
por: Prete, Alessandro, et al.
Publicado: (2020)

SUN-037 Discordant Serum 17-hydroxyprogesterone and Androstenedione in the Management of Congenital Adrenal Hyperplasia: Are 11-oxygenated Androgens Useful?
por: Jha, Smita, et al.
Publicado: (2020)

Response to Letter to the Editor: “Prevention of Adrenal Crisis: Cortisol Response to Major Stress Compared to Stress Dose Hydrocortisone Delivery”
por: Prete, Alessandro, et al.
Publicado: (2020)

Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE)
por: Han, Thang S, et al.
Publicado: (2013)

Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency
por: Bannon, Christopher A. M., et al.
Publicado: (2021)

Response to Letter to the Editor from Chee et al: “Prevention of Adrenal Crisis: Cortisol Response to Major Stress Compared to Stress Dose Hydrocortisone Delivery”
por: Prete, Alessandro, et al.
Publicado: (2020)

Sexuality in Males With Congenital Adrenal Hyperplasia Resulting From 21-Hydroxylase Deficiency
por: Gehrmann, Katharina, et al.
Publicado: (2019)

Morphologic and Molecular Characterization of Adrenals and Adrenal Rest Affected by Congenital Adrenal Hyperplasia
por: Kolli, Vipula, et al.
Publicado: (2021)

The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy
por: Dineen, Rosemary, et al.
Publicado: (2020)

Patients with Hypocortisolism Treated with Continuous Subcutaneous Hydrocortisone Infusion (CSHI): An Option for Poorly Controlled Patients
por: Mortensen, Malene Lyder, et al.
Publicado: (2023)

Would Cortisol Measurements Be a Better Gauge of Hydrocortisone Replacement Therapy? Congenital Adrenal Hyperplasia as an Exemplar
por: Hindmarsh, Peter C, et al.
Publicado: (2020)

Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia
por: Dauber, Andrew, et al.
Publicado: (2010)

Effects of Systemically Administered Hydrocortisone on the Human Immunome
por: Olnes, Matthew J., et al.
Publicado: (2016)

Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients
por: Arlt, Wiebke, et al.
Publicado: (2010)

Hydrocortisone in Minor Orthopædic Conditions
por: Kyle, J., et al.
Publicado: (1957)

Bolus or continuous hydrocortisone – that is the question
por: Weber-Carstens, Steffen, et al.
Publicado: (2007)

Hydrocortisone in septic shock: is it worth it?
por: Young, Paul J.
Publicado: (2023)

General theory of inflammation: patient self-administration of hydrocortisone safely achieves superior control of hydrocortisone-responding disorders by matching dosage with symptom intensity
por: Irwin, John B, et al.
Publicado: (2019)

A Prospective Cross-Over Study of Tissue Glucocorticoid Metabolism in Patients With Adrenal Insufficiency: The Effects of Dual-Release Hydrocortisone Therapy
por: Dineen, Rosemary Anne, et al.
Publicado: (2021)

Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy
por: Dineen, Rosemary A, et al.
Publicado: (2023)

11-Oxygenated Androgens Are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency
por: Turcu, Adina F., et al.
Publicado: (2017)

Increased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia: A Primary Care Database Cohort Study
por: Tresoldi, Alberto S, et al.
Publicado: (2019)

The Contribution of Online Peer-to-Peer Communication Among Patients With Adrenal Disease to Patient-Centered Care
por: Kauw, Dirkjan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a1rj73nujvfgpeepu8e428g0aj